Domperidone treats dyspepsia caused by delayed gastric emptying, gastroesophageal reflux, and esophagitis. -Upper abdominal distension, bloating, upper abdominal pain;-warm air, flatulence;-nausea, vomiting;-heartburn with or without refluxing stomach contents in the mouth. Domperidone can also treat nausea and vomiting caused by functional, organic, infectious, dietary, radiotherapy or chemotherapy. The use of dopamine receptor agonists (such as levodopa, bromocriptine, etc.) to treat nausea and vomiting caused by Parkinson's disease is a specific indication for this product.
| Test Items |
Specification |
| Appearance |
White crystalline or crystalline powder, odorless |
| Solubility |
Freely soluble in water, insoluble in ethanol |
| Identification |
Comply with the standard |
| PH |
6.0-7.5 |
| Clarity and color of solution |
Should be clear and colorless |
| Chlorides |
≤0.05% |
| Ammonium salt |
≤0.05% |
| Iron |
≤0.01% |
| Phosphates |
≤0.1% |
| Loss on drying |
≤6.0% |
| Heavy metals |
≤0.0005% |
| Arsenic |
≤0.0001% |
| Bacterial endotoxins |
<0.3EU/mg |
| Microbial contamination |
Total bacterial count≤1000cfu/g |
| Yeast & molds≤100cfu/g |
| E.coli: not detected |
| Related substances |
5'-CMP≤0.3% |
| Other signle 1 impurities≤0.2% |
| Other total impurities≤0.7% |
| Residual solvent |
Ethanol≤0.5% |
|
|
| Assay |
NLT 98.0% |
| |
|
Audited Supplier 
){kind=link}
){kind=link}